Merck KGaA, Darmstadt, Germany | LinkedIn (original) (raw)
``
Info
We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Privacy Statement: https://www.emdgroup.com/en/privacy-statement.html
Branche
Arzneimittelherstellung
Größe
10.001+ Beschäftigte
Hauptsitz
Darmstadt
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Spezialgebiete
Phamaceutical, Chemical, Technology und Science
Orte
Beschäftigte von Merck KGaA, Darmstadt, Germany
Updates
- Merck KGaA, Darmstadt, Germany hat dies direkt geteilt
205.028 Follower:innen
2 Wochen
Exciting news! We’re investing $76 million to triple our Antibody-Drug Conjugate (ADC) manufacturing capacity in St. Louis, Missouri. This expansion reinforces our commitment to advancing these cutting-edge novel therapies, and to our clients and ultimately patients. ADCs precisely target cancer cells, sparing healthy ones—one of the most promising advances in cancer treatment today. Together with our clients, we’re unlocking ADCs’ full potential to impact life and health with science. Learn more here: http://ms.spr.ly/6048W3d52 -
105.705 Follower:innen
5 Monate
Big news! Today, we announced the opening of our newly expanded Life Science distribution center in Schnelldorf, Germany. The investment of € 180 million added 25,000 square meters to the site, almost doubling its size. It now includes a new manual down filling operation and additional space for the distribution of a wide range of products to laboratories and research facilities all around the world. Congratulations to the team -
105.705 Follower:innen
6 Monate Bearbeitet
We have signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million. Mirus Bio is a specialist in the development and commercialization of transfection reagents. These reagents play a key role in the production of viral vectors for cell and gene therapies. The acquisition will advance our integrated offering for viral vector manufacturing and complements the existing portfolio for development and production of novel modalities – a key growth area for MilliporeSigma. More: https://lnkd.in/eBde6hbZ[📷 from our Carlsbad, California manufacturing facility]
Definite-Agreement-Mirus-Bio | Merck KGaA, Darmstadt, Germany emdgroup.com -
105.705 Follower:innen
10 Monate
As 2023 draws to a close, we want to take a moment to look back at a year of transformation and progress, and the achievements that characterized 2023 and will continue to shape our work in the future. We want to say thank you to our community, our employees and all the people who share our love and passion for science and technology. 📖 Join us in revisiting the highlights of 2023 in this article! #2023 #YearEnd #Recap
Looking back at 2023 Merck KGaA, Darmstadt, Germany auf LinkedIn -
105.705 Follower:innen
11 Monate
Together with p-Chip we integrated their microtransponder technology as a crypto-anchor into a framework solution. This achievement marks an important milestone in enabling the creation of secure #digital twins of physical products. “We are committed to empowering companies to fully leverage the advantages of the Industrial Internet of Things and develop digital twins of single objects they can really trust. The joint solution with p-Chip comprises a comprehensive combination of software and hardware. This enables our customers to effortlessly develop their individual digital applications, tailored to their unique requirements," said Dr. Thomas Endress. "p-Chip microtransponders play an integral role in our new partner’s robust digital solution. As industries leverage #blockchain, artificial intelligence #AI, and #machinelearning to solve complex challenges, our digital twin enabling technology delivers the breakthrough levels of visibility, traceability, and security needed for companies to achieve dramatic operational efficiencies," p-Chip CEO Joe Wagner said. Find more information here: https://lnkd.in/d_YCbXqR #digitaltwin #digital #innovation #IIOT #science
Digital Twin Collaboration p-Chip | Merck KGaA, Darmstadt, Germany emdgroup.com